Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis

Amyloid

Volumn 13, Issue 3, 2006, Pages 170-177

  Liepnieks, Juris J ^a   Wilson, Donald L ^b   Benson, Merrill D ^a,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MIDWEST EYE INSTITUTE   (United States)

^c RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cardiac amyloid; Hereditary amyloidosis; Proteolysis; Transthyretin; Transthyretin fragments; Vitreous amyloid

Indexed keywords

AMYLOID; GUANIDINE; PREALBUMIN;

AMYLOIDOSIS; ARTICLE; HEART; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VITREOUS BODY;

AMINO ACID SUBSTITUTION; AMYLOID; AMYLOIDOSIS; ISOLEUCINE; MYOCARDIUM; PREALBUMIN; VITREOUS BODY;

EID: 33750364454     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.1080/13506120600877003     Document Type: Article

References (31)

1. Sandgren O. Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement. Surv Ophthalmol 1995;40:173-196.
2. Benson MD. Amyloidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, editors. The metbolic and molecular bases of inherited disease. 8th ed. New York: McGraw Hill Book Company; 2000. pp 5345-5378.
3. Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid J Protein Folding Disord 2003;10:160-184.
4. Martone RL, Herbert J, Dwork A, Schon EA. Transthyretin is synthesized in the mammalian eye. Biochem Biophys Res Commun 1988;151:905-912.
5. Ando Y, Ando E, Tanaka Y, Yamashita T, Tashima K, Suga M, Uchino M, Negi A, Ando M. De novo amyloid synthesis in ocular tissue in familial amyloidotic polyneuropathy after liver transplantation. Transplantation 1996;62:1037-1038.
6. Ando E, Ando Y, Haraoka K. Ocular amyloid involvement after liver transplantation for polyneropathy. Ann Intern Med 2001;135:931-932.
7. Munar-Qués M, Salvá-Ladaria L, Mulet-Perera P, Solé M, López-Andreu FR, Saraiva MJM. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin. Amyloid Int J Exp Clin Invest 2000;7:266-269.
8. Yazaki M, Liepnieks JJ, Kincaid JC, Benson MD. Contribution of wild-type transthyretin to hereditary peripheral nerve amyloid. Muscle Nerve 2003;28:438-442.
9. Dwulet FE, Benson MD. Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss). J Clin Invest 1986;78:880-886.
10. Pras M, Schubert M, Zucker-Franklin D, Rimon A, Franklin EC. The characterization of soluble amyloid prepared in water. J Clin Invest 1968;47:924-933.
11. Schagger H, Von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1-100 kDA. Anal Biochem 1987;166:368-379.
12. Herbert J, Wilcox JN, Pham K-TC, Fremeau RT Jr, Zeviani M, Dwork A, Soprano DR, Makover A, Goodman DS, Zimmerman EA, Roberts JL, Schon EA. Transthyretin: a choroid plexus-specific transport protein in human brain. Neurology 1986;36:900-911.
13. Thylén C, Wahlqvist J, Haettner E, Sandgren O, Holmgren G, Lundgren E. Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation. EMBO J 1993;12:743-748.
14. Ando Y, Ando E, Ohlsson P-I, Olofsson A, Sandgren O, Suhr O, Terazaki H, Obayashi K, Lundgren E, Ando M, Negi A. Analysis of transthyretin amyloid fibrils from vitreous samples in familial amyloidotic polyneuropathy (Val30Met). Amyloid Int J Exp Clin Invest 1999;6:119-123.
15. Ando Y, Terazaki H, Nakamura M, Ando E, Haraoka K, Yamashita T, Ueda M, Okabe H, Sasaki Y, Tanihara H, Uchino M, Inomata Y. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation. Transplantation 2004;77: 345-349.
16. Felding P, Fex G, Westermark P, Olofsson BO, Pitkänen P, Benson L. Prealbumin in Swedish patients with senile systemic amyloidosis and familial amyloidotic polyneuropathy. Scand J Immunol 1985;21:133-140.
17. Gorevic PD, Prelli FC, Wright J, Pras M, Frangione B. Systemic Senile Amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: Immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J Clin Invest 1989;83:836-843.
18. Bergström J, Gustavsson Å, Hellman U, Sletten K, Murphy CL, Weiss DT, Solomon A, Olofsson B-O, Westermark P. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology. J Pathol 2005;206:224-232.
19. Cornwell GG III, Sletten K, Johansson B, Westermark P. Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin. Biochem Biophys Res Commun 1988;154:648-653.
20. Westermark P, Sletten K, Johansson B, Cornwell GG III. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 1990;87:2843-2845.
21. Gustavsson Å, Jahr H, Tobiassen R, Jacobson DR, Sletten K, Westermark P. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis. Lab Invest 1995;73:703-708.
22. Westermark P, Sletten K, Olofsson B-O. Prealbumin variants in the amyloid fibrils of Swedish familial amyloidotic polyneuropathy. Clin Exp Immunol 1987;69:695-701.
23. Nordlie M, Sletten K, Husby G, Ranløv PJ. A new prealbumin variant in familial amyloid cardiomyopathy of Danish origin. Scand J Immunol 1988;27:119-122.
24. Hermansen LF, Bergman T, Jörnvall H, Husby G, Ranløv I, Sletten K. Purification and characterization of amyloid-related transthyretin associated with familial amyloidotic cardiomyopathy. Eur J Biochem 1995;227:772-779.
25. Wallace MR, Dwulet FE, Conneally PM, Benson MD. Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis. J Clin Invest 1986;78:6-12.
26. Yazaki M, Tokuda T, Nakamura A, Higashikata T, Koyama J, Higuchi K, Harihara Y, Baba S, Kametani F, Ikeda S-I. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant Wild-type transthyretin. Biochem Biophys Res Commun 2000;274:702-706.
27. Blake CCF, Geisow MJ, Oatley SJ. Structure of prealbumin: secondary, tertiary, and quaternary interactions determined by fourier refinement at 1·8 Å . J Mol Biol 1978;121:339-356.
28. Hamilton JA, Steinrauf LK, Braden BC, Murrell JR, Benson MD. Structural changes in transthyretin produced by the Ile84Ser mutation which result in decreased affinity for retinol-binding protein. Amyloid Int J Exp Clin Invest 1996;3:1-12.
29. Shimizu T, Matsuoka Y, Shirasawa T. Biological significance of isoasparteate and its repair system. Biol Pharm Bull 2005; 28:1590-1596.
30. Robinson NE, Robinson AB. Molecular clocks. Proc Natl Acad Sci USA 2001;98:944-949.
31. Hanes D, Zech LA, Murrell J, Benson MD. Metabolism of Normal and Met30 Transthyretin. In: Coburn SP, Townsend DW, editors. Advances in Food and Nutrition Research, vol. 40. San Diego: Academic Press; 1996. pp 149-155.